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Introduction: Protein extraction from formalin-fixed paraffin-embedded (FFPE) tissues is challenging due to
extensive molecular crosslinking that occurs upon formalin fixation. Reverse-phase protein array (RPPA) is a
high-throughput technology, which can detect changes in protein levels and protein functionality in numerous
tissue and cell sources. It has been used to evaluate protein expression mainly in frozen preparations or FFPE-based
studies of limited scope. Reproducibility and reliability of the technique in FFPE samples has not yet been
demonstrated extensively. We developed and optimized an efficient and reproducible procedure for extraction of
proteins from FFPE cells and xenografts, and then applied the method to FFPE patient tissues and evaluated its
performance on RPPA.
Results: Fresh frozen and FFPE preparations from cell lines, xenografts and breast cancer and renal tissues were
included in the study. Serial FFPE cell or xenograft sections were deparaffinized and extracted by six different
protein extraction protocols. The yield and level of protein degradation were evaluated by SDS-PAGE and Western
Blots. The most efficient protocol was used to prepare protein lysates from breast cancer and renal tissues, which
were subsequently subjected to RPPA. Reproducibility was evaluated and Spearman correlation was calculated
between matching fresh frozen and FFPE samples.
The most effective approach from six protein extraction protocols tested enabled efficient extraction of
immunoreactive protein from cell line, breast cancer and renal tissue sample sets. 85% of the total of 169 markers
tested on RPPA demonstrated significant correlation between FFPE and frozen preparations (p < 0.05) in at least
one cell or tissue type, with only 23 markers common in all three sample sets. In addition, FFPE preparations
yielded biologically meaningful observations related to pathway signaling status in cell lines, and classification of
renal tissues.
Conclusions: With optimized protein extraction methods, FFPE tissues can be a valuable source in generating
reproducible and biologically relevant proteomic profiles using RPPA, with specific marker performance varying
according to tissue type.
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Formalin fixation coupled with paraffin embedding
(FFPE) is the standard tissue fixation and storage method
adopted by most health institutions. FFPE tissues are
highly stable, and can be stored at room temperature.
Proteins are stabilized through cross-linking and cell or
tissue structure is mainly preserved. Multiple reports
show that proteins and protein modifications such as
phosphorylation are maintained and can be determined
years later by immunohistochemistry [1].
However, releasing proteins from FFPE tissues for
proteomic analysis has proven to be a daunting task.
The extensive molecular crosslinking that occurs upon
formalin fixation reduces protein extraction efficiency
and may interfere with immunoreactivity [2], warrant-
ing the development of more efficient extraction
methods [3]. Several proteomic studies using archival
FFPE tissues have been reported in recent years. The
majority of these studies employ protein extraction
methods that are derived from heat-induced antigen
retrieval techniques originally developed for immuno-
histochemistry [4-8].
In the era of personalized medicine, new therapeutic
and diagnostic options are rapidly becoming available to
cancer patients, based on novel high-throughput tech-
nologies. Reverse-phase protein array (RPPA) can effi-
ciently quantify changes in protein levels and protein
functionality in numerous tissue and cell sources [9-12].
This methodology provides a suitable approach in gener-
ating high-throughput protein profiles in a robust quan-
titative manner, providing an advantage over traditional
methods such as immunohistochemistry [13,14]. RPPA
has been used to evaluate protein expression mainly in
frozen preparations. Reproducibility and reliability of the
technique in FFPE samples have not been previously
assessed extensively.
In this study, we developed and optimized an efficient
and reproducible procedure for extraction of proteins
from FFPE tissues. We demonstrate that this approach
produces reliable results and biologically meaningful
proteomic profiles generated by RPPA.Table 1 Protein extraction methods
Method 1 Method 2 Metho






incubation at 80o C ✓ ✓
The differences in buffer type and conditions between the protocols for protein extResults
Optimization of the protein extraction method from
paraffin-embedded samples
Paraffin-embedded specimens comprise a wide variety of
tissues, which may include samples of very limited
amount, such as core biopsies. Protein material extracted
from paraffin-embedded specimens may be of lower
quality compared to frozen equivalents, because of deg-
radation or dephosphorylation of proteins due to the for-
malin fixation and embedding process or differences in
time taken for preparation. It is therefore important to
evaluate protein extraction methods for optimal per-
formance, both in terms of quantity as well as quality.
FFPE blocks generated from breast cancer cell lines
and xenografts were used for preliminary studies due
to ready availability and the ability to control condi-
tions of preparation and handling. We applied differ-
ent protein extraction protocols to cell lines and
xenografts embedded in paraffin, in order to evaluate
yield and protein quality. The protocols used in this
study were versions of previously described RPPA pro-
tocols [9,15], modified to include deparaffinization
steps. Additional modifications were adopted based on
an extensive literature review [16-18]. A commercially
available protocol (Qproteome FFPE Tissue Kit from
Qiagen, Germany) was also assessed. In particular,
method 1 was a modification of the RPPA extraction
protocol [9,15] to include deparaffinization steps.
Methods 2 and 3 are versions of method 1 based on
literature [16]. Methods 4–6 are based on method 2
with buffers of varying pH (described in Table 1).
We first tested the protein concentration of the
extracts recovered in standard volume, using the various
methods, for both cell and xenograft preparations.
Method 4 (the modification of method 2, with pH = 9)
showed the highest yield (protein concentration of 4.25
mg/ml in breast cancer cell FFPE preparations, and 2.43
mg/ml in xenograft FFPE preparations) compared to the
other methods (Figure 1A). We then evaluated the de-
gree of degradation of the extracted protein. Specifically,






raction from FFPE cells and tissues used in the study are shown.
Figure 1 Protein yield and signal quality using modified extraction methods. 1A: Protein concentration of lysates generated from breast
cancer cell FFPE plugs (upper panel) and FFPE xenografts (lower panel) using different extraction methods is shown. 1B: Western blots for select
protein markers are shown. Extracts from breast cancer cell lines incubated with or without EGF (marked “EGF” and “ctrl” respectively) were
derived from FFPE or fresh preparations using different extraction methods and subjected to western blotting. 1C: Western blots using lysates
from xenografts are shown. M1 = method 1; M3 = method 3; M4 = method 4; F = lysate from frozen preparation. Arrows point to low molecular
weight bands attributed to protein degradation.
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extracted protein material from frozen preparations,
stained the gels with Coomassie blue, and assessed pro-
tein degradation as evidenced by the presence of low
molecular weight bands or loss of signal. Coomassie
blue staining demonstrated that the extracts from
paraffin-embedded specimens (cell plugs and xenograft
tissues) showed some prominent lower weight products
(Additional file 6: Figure S2A, B), but with recoverable
protein at high molecular weights as well. In addition to
degradation, differences in lysis buffers may contribute
to the variability in the observed banding patterns.
Western blot analysis for select signaling molecules con-
firmed that there was some protein degradation in the
FFPE samples, which was reflected by lower molecular
weight bands, but the bands of the correct molecular
weight were strong, as in the case of frozen samples
(Figure 1B, C). Importantly, the phosphorylation status
of the proteins tested was conserved, as evidenced by
phospho-AKT and phospho-ERK levels comparable
between FFPE and frozen preparations.RPPA on paraffin-embedded specimens
After establishing that method 4 exhibited the highest pro-
tein yields and showed only partial protein degradation on
Coomassie staining and western blots, we proceeded with
RPPA, in order to evaluate protein expression in extracts
processed with method 4. In particular, extracts derived
from paraffin-embedded cell line samples and their
matched fresh frozen preparations were spotted on arrays
and stained for 169 protein markers. Each fresh frozen (FF)
and FFPE sample was represented by two replicate prepara-
tions on the array. Each replicate preparation was serially
diluted and spotted as described in Methods and Additional
file 5: Figure S1. The resulting data were normalized using
GSMN (see Methods). A breast and ovarian cancer cell line
panel of six lines grown under different cell culture condi-
tions (serum-starved media, addition of growth factors
(EGF or IGF) or pharmacological inhibitors such as PI3K
inhibitor LY294002 and MAPK inhibitor PD98059) pro-
vided a dynamic range for phosphorylation events.
The purpose of this experiment was to evaluate RPPA
performance on paraffin-embedded material in a highly
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addressed reproducibility of the technique by estimating
the Spearman correlation coefficient between replicate
preparations across the protein markers tested. Both for-
malin fixed paraffin-embedded (FFPE) and frozen repli-
cates performed reproducibly. Specifically, 91.42% of
markers showed reproducibility between frozen sample
replicates with spearman coefficient equal or greater
than 0.7 (p < 3.5*10-7). For the FFPE sample replicates,
70.41% of markers showed reproducible results (spear-
man coefficient > =0.7, p < 1.48*10-6) (Figure 2).
In addition to technical reproducibility, we assessed
how similar the FFPE preparations performed compared
to matched fresh frozen specimens. After estimating the
Spearman coefficient between FFPE and matched FF
samples across all protein markers in the RPPA experi-
ment, we observed that there was statistically significant
correlation (cutoff p <0.05, spearman coefficient > 0.36)
for 45% of the markers tested (77 markers) (Table 2).
For the markers that did not demonstrate significantFigure 2 RPPA reproducibility between replicate preparations.
Reproducibility between replicate preparations is expressed as the
percentage of markers (% occurrence) at distinct intervals of
Spearman coefficient.correlation between FFPE and their matched frozen pre-
parations, we sought to investigate potential reasons for
the apparent lack of correlation. First, we considered the
case of overall low signal. Indeed, 17% of the protein mar-
kers exhibited low intensities (log2 intensities of < −2), for
all the samples tested. We then evaluated whether large
intensity differences between the FFPE and FF sample sets
may account for the observed low correlation. 32% of all
the protein markers had significantly different signal in-
tensities (> 2-fold, p < 5*10-6) between the FFPE and FF
sets and low correlation between FFPE and FF intensities
(Table 2). In fact, there was a significant enrichment of
markers with different signal intensities between FFPE
and FF in the low correlation group (59% of markers with
low correlation between FFPE and FF exhibited high in-
tensity differences between the two preparations, whereas
only 23% of markers with good correlation between FFPE
and FF had high intensity differences). There was no ap-
parent bias towards a specific preparation type, with
overall low or overall high intensities being equally dis-
tributed between the FFPE and FF sets.
The remaining 6% of markers (Table 2) with poor cor-
relation between FFPE and FF were found to have poor
reproducibility between replicates for either FFPE or FF
preparations, due to yet undetermined reasons.
To test whether results derived from FFPE specimens
could be used to identify biologically relevant changes in
signaling events, we focused on phospho protein mar-
kers, where levels were altered by changing culture con-
ditions and applying pharmacological interventions. In
particular, we expected phospho-AKT (pAKTser473) and
its downstream effector phospho-S6 (pS6ser235) to be
induced by growth factor addition in the culture media,
and inhibited by PI3K inhibitor (LY294002). On the other
hand, these markers should not be affected directly by a
MAPK inhibitor (PD98059). Indeed, we observed that
both phospho-AKT and phospho-S6 exhibited the antici-
pated changes in terms of rank order in matched FFPE
and frozen samples (Figure 3). Specifically, the average
normalized log2 signal intensities of both pAKTser473
and pS6ser235 increased by 3-fold and 1.76-fold respect-
ively in the epidermal growth factor (EGF)-induced cul-
tures in frozen preparations. pS6ser235 was increased by
2.05-fold in EGF-treated FFPE preparation, similar to
that in the EGF-treated frozen preparation, indicating
that the pS6ser235 site was robust to handling. In con-
trast, EGF-induced elevation in pAKTser473 was not
detected in the FFPE preparation, suggesting that pAKT
was dephosphorylated during handling. Compared to
EGF-treated cultures, pAKTser473 and pS6ser235 levels
were markedly reduced in the LY294002-treated cultures,
as anticipated (pAKTser473; 2.3-fold reduction in frozen
and 5.2-fold reduction in FFPE preparations, pS6ser235;
>10-fold reduction in frozen and 4.66-fold reduction in
Table 2 Distribution of RPPA-detected protein markers depending on their performance between frozen and FFPE
preparations
Markers with p < 0.05
between FFPE and FF
Markers with large intensity
difference between FFPE and FF
Markers with low intensity
in both FFPE and FF
Markers with low replicate
reproducibility (R < 0.7)
Cell lines 77 (45%) 54 (32%) 28 (17%) 10 (6%)
Breast cancer set 54 (32%) 81 (48%) 25 (15%) 9 (5%)
Renal cancer set 107 (64%) 31 (18%) 7 (4%) 24 (14%)
Markers with high correlation (p < 0.05) between frozen and FFPE preparations, large intensity differences, low signal or low reproducibility for cell lines, breast
cancer set and renal set are shown.
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effects of EGF on pAKTser473 and pS6ser235 in either
FFPE or frozen preparations (Figure 3).
The experiment on cell lines provided evidence sup-
portive of applicability of high-throughput protein ex-
pression detection from FFPE specimens. We then
sought to analyze RRPA-based protein expression pat-
terns for a set of FFPE breast cancer tissues from
human patients. In particular, we screened 49 breast
cancer samples along with an equal number of replicate
preparations and matched frozen samples for expres-
sion of 169 protein markers. The replicates from theFigure 3 Phosphorylation patterns of the AKT pathway
according to cell treatment and preparation type. Phospho-AKT
and phospho-S6 were detected using RPPA. The lysates spotted on
the protein arrays were derived from breast and ovarian cancer cell
lines treated with growth factors or inhibitors. Starved = serum-
starved cell cultures; EGF = growth factor treated; LY = LY294002;
PD = PD98059.same specimen performed similarly for both FFPE and
frozen preparations (Figure 2). Specifically, 92.3% of
markers showed reproducibility between frozen sample
replicates with spearman coefficient equal or greater
than 0.7 (p < 5*10-10). For the FFPE sample replicates,
96.4% of markers showed reproducible results (spear-
man coefficient > =0.7, p < 6.35*10-10). When the FFPE
data were compared to their frozen counterparts, 32%
demonstrated similar expression patterns (cutoff p <0.05,
spearman coefficient > 0.28) between FFPE and matched
frozen samples (Table 2). Importantly, 48% of the mar-
kers exhibited statistically significant intensity differences
(> 2-fold, p < 5*10-6) between frozen and FFPE prepara-
tions, implying that a number of processes affecting pro-
tein integrity such as handling, formalin fixation, protein
extraction buffers and conditions, as well as tissue het-
erogeneity may contribute to differences between FFPE
and matched frozen samples. Nevertheless for those pro-
teins demonstrating correlations, FFPE may provide a
usable source of material.
We also assessed two additional tissue types, renal
cancer and normal renal cortex. These specimens were
paraffin-embedded following a method similar to the
one employed in the cell line experiment. We processed
15 renal cancer samples and 16 normal renal cortex
samples from human patients. Each sample was repre-
sented by two replicate frozen and two replicate FFPE
preparations. Similarly to our previous experiments, we
established technical reproducibility. Specifically, 89.94%
of markers showed reproducibility between frozen sam-
ple replicates with spearman coefficient equal or greater
than 0.7 (p < 2.5*10-7). For the FFPE sample replicates,
90.53% of markers showed reproducible results (spear-
man coefficient > =0.7, p < 3.66*10-7) (Figure 2). Cor-
relation between FFPE and frozen preparations was
improved compared to the cell line and breast cancer
experiments, with 64% of the markers exhibiting p < 0.05
(spearman coefficient > 0.35)(Table 2). Importantly, the
RPPA-based global protein expression profile of the FFPE
preparations was able to distinguish between normal renal
and tumor samples, as evidenced by means of principal
component analysis (Figure 4).
Comparing marker performance across all three
experiments, the majority of protein markers (85%)
Frozen FFPE
Figure 4 Principal component analysis (PCA) of protein expression profiles of the renal set. Protein expression profiles depicted as PCA
plots were generated using lysates from frozen (left) or FFPE preparations (right) spotted on protein arrays using the RPPA approach. The ellipses
were centered based on the means of the first and second principal components for each group (normal or tumor), and drawn using the
variation factors that are the products of the eigenvector and the square root of eigenvalues calculated from the variances and covariances of
the first and second principal components. The two groups are separated, as indicated by their means.
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frozen preparations (p < 0.05) in at least one experiment
(cell lines, breast cancer set or renal set), with 23 mar-
kers exhibiting significant correlation in all three data
sets (Figure 5A). There was variability between breast,
renal and cell line data for each antigen suggesting that
tissue specific characteristics likely contribute to total or
phospho protein stability or recovery. The 26 markers
with poor performance as evidenced by low frozen vs.
FFPE correlations are shown in Figure 5B.
In order to demonstrate the applicability of RPPA from
FFPE materials in a clinical laboratory setting, we sought
to validate our results by comparing them to available
immunohistochemistry-generated data of clinically sig-
nificant markers. In particular, we compared our breast
cancer RPPA data for one of our best performing markers
(Figure 5A), PR (progesterone receptor), with correspond-
ing immunohistochemical measurements. As shown in
Figure 6, the breast cancer samples characterized as PR-
positive using immunohistochemistry showed significantly
higher PR protein expression levels in RPPA, compared to
the PR-negative tumors. This was the case for both FFPE
(PR-negative median normalized logarithmic intensity =
−1.19; PR-positive median normalized logarithmic inten-
sity = 0.38; p < 0.0008) and frozen samples (PR-negative
median normalized logarithmic intensity = −1.19; PR-
positive median normalized logarithmic intensity = −0.06;
p < 2.5*10-5).Discussion
In this study, we have shown that FFPE tissues can be a
valuable source in generating reproducible and biologic-
ally relevant proteomic profiles using reverse-phase pro-
tein arrays (RPPA).
We first evaluated a broad range of extraction condi-
tions from FFPE tissues, including deparaffinization, re-
hydration, buffer components, pH conditions and
temperatures. In the past, antigen retrieval techniques
were used that mainly focused on applying high tempera-
tures in appropriate buffers, facilitating the hydrolysis of
formalin-induced crosslinks [19]. Subsequent studies
hypothesized that the pH range may affect antigen re-
trieval and quality of immunostaining. In particular, the
Tris–HCl buffer tended to produce better results at
higher pH (pH = 8–9) [20]. Other authors have suggested
that low pH around 4.0 can produce peptides resulting
from acid-catalyzed aspartic acid cleavage, therefore low-
ering protein yield [21]. Addition of a reducing agent did
not alter protein recovery significantly compared to pH
[16]. Consistent with these studies, we observed that the
highest protein yields were achieved using Tris–HCl con-
taining 2% sodium dodecyl sulfate and 0.2 M glycine at
pH 9.0 when heated at 100°C for 20 min, followed by in-
cubation at 80°C for 2 h.
With respect to protein degradation, both Coomassie
staining and western blot analysis revealed lower-weight
products in the FFPE cell and xenograft samples,




























































Figure 5 Protein markers and their correlation between FFPE and frozen preparations. A: Markers with high correlation (p < 0.05) between
frozen and FFPE preparations in all of the studied cell and tissue sets are shown. B: Markers with poor correlation (p >0.05) for all three sets
are shown.
Guo et al. Proteome Science 2012, 10:56 Page 7 of 12
http://www.proteomesci.com/content/10/1/56consistent with previous observations [5,22]. Since we
initiated protein fixation immediately after harvesting,
protein degradation may be the result of the duration of
fixation, rather than solely due to handling prior to fix-
ation. Our 16-hour fixation for cells and 24-hour fixation
for xenografts may have led to challenges with isolating
proteins from the fixed tissue, but this duration of fix-
ation is commonly encountered in pathology laboratories.
Novel extraction methods are continuously being devel-
oped to specifically address the duration of fixation in
pathology laboratories, and it will be beneficial in the fu-
ture, to adapt these protocols to being compatible with
RPPA [23]. Besides the observed partial degradation, the
quality of the signal was overall comparable to frozen
extractions. This implies that partial protein degradation
or protein modification may occur in FFPE samples, but
not to the extent of significantly lowering protein yield or
signal detection. This is an important point, since the
downstream application, RPPA, represents a dot blot, andutilizes antibodies recognizing epitopes under denaturing
conditions. This supports the notion that even partially
degraded proteins will be readily detected using the RPPA
approach, with little variation when compared to intact
protein. Indeed, the dot blot approach of the RPPA may
be even less influenced by protein degradation than the
western blotting approach as RPPA only requires that the
antibody epitope be intact and not the complete protein.
This is supported by RPPA data which show that the
average signal detected from the FFPE preparations was
similar to that of the frozen counterparts (data not
shown). In fact, the antibodies that exhibited marked dif-
ference between frozen and FFPE preparations across
experiments (Table 2) did so without showing any bias
towards a particular preparation. The observed differ-
ences in intensity for those markers between FFPE and
frozen samples may be due to differential protein recov-
ery rather than protein degradation, as suggested by pre-

















PR PR+ PR PR+
FFPE samples Frozen samples
Figure 6 RPPA-generated protein expression levels of PR according to clinical PR status. Normalized logarithmic intensities corresponding
to RPPA-generated protein expression levels of PR in FFPE and matched frozen breast tumor samples are shown, grouped according to
immunohistochemistry-based clinical status of PR (PR - = PR-negative; PR + = PR-positive status).
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FFPE compared to frozen or vice versa depending on the
extent of protein recovery. Indeed, it may be appropriate
to use other approaches such as clustering or correlations
with clinical and other characteristics to define the “gold
standard” rather than assuming that frozen samples rep-
resent the “truth”.
Previous studies have tested the applicability of RPPA
on FFPE materials [3,24-27]. In this present study, we fol-
lowed a systematic approach in evaluating feasibility, re-
producibility and biological significance of RPPA applied
on two distinct tissue types and for a wide range of pro-
tein markers. We first established a cell plug model, in
order to eliminate experimental variability due to storage
duration of FFPE tissue blocks, differences in fixing times,
autolysis due to delayed fixing, individual differences in
samples, anatomical or regional heterogeneity, and other
possible sources of variability commonly occurring in
human tissue FFPE preparations. The predictable patterns
of protein phosphorylation according to pharmacological
manipulations applied to cultured cells proved particu-
larly useful in this study, in order to determine whether
both FFPE and frozen preparations of treated cells were
capable of reproducing the anticipated results. Changes in
the AKT downstream effector phospho-S6 were inhibited
or induced by inhibitors or growth factors to a similar de-
gree in both FFPE and frozen cells. However, the
increases induced by EGF in pAKT were not detected inFFPE samples suggesting degradation of pAKT. Neverthe-
less, the decrease in pAKT induced by LY294002 was
faithfully captured in both frozen and FFPE preparations.
A striking correlation of phosphorylation status between
upstream activator and downstream effector was
observed in tissues. In particular, factors in the same sig-
naling pathway, AKT, 4EBP1 and S6, were coordinately
phosphorylated in both FFPE and frozen preparations in
the same patient samples interrogated (Figure 5A). In-
deed, the correlation in patient samples was higher than
that in the cell line samples. The usefulness of proteomic
profiling of FFPE tissues in producing biologically mean-
ingful information is further supported by the observation
that global protein expression information from FFPE
samples was capable of accurately categorizing renal tis-
sues according to their underlying biology i.e. separating
cancer from normal.
Using different types of tissues and cells in this study
revealed a wealth of differences with respect to their
proteomic profiles. As anticipated, protein markers per-
formed markedly differently according to tissue type.
Many of them were not detected according to tissue
type, regardless of FFPE or frozen preparation status
(Table 2). With respect to markers that demonstrated
good correlation between FFPE and matched frozen
samples, only 23 markers were common across all tissue
sets (Figure 5A), as a testament to marked biological di-
versity of different cell lineages. This also suggests that it
Guo et al. Proteome Science 2012, 10:56 Page 9 of 12
http://www.proteomesci.com/content/10/1/56may be necessary to select different antibodies to inter-
rogate the diverse array of tissue lineages as protein and
particular phosphoprotein stability may be tissue
specific.
With respect to the reproducibility of the approach, it
is important to note that separate preparations, either
FFPE or frozen, from the same tissue sample (replicates)
performed similarly on RPPA (Figure 2). This questions
the notion that tissue heterogeneity between replicate
preparations may introduce critical variations in protein
profiling preventing useful interpretation if laser-capture
microdissection is not applied [28]. It is noteworthy that
our replicate preparations were derived from adjacent
serial sections or pieces, therefore limiting tumor hetero-
geneity. But unlike our replicate preparations from
within the same sample, FFPE and matched frozen sam-
ples came from tissue pieces that were located a signifi-
cant distance from one another, especially in the case of
breast cancer samples. Thus, tissue heterogeneity may
have contributed to discrepancies between FFPE and
matched frozen RPPA results. This is consistent with re-
cently published studies of spatial heterogeneity of DNA
mutations [29].
With respect to the applicability of RPPA in the clin-
ical routine setting, it is encouraging that the RPPA-
based measurements of PR correlated significantly with
the immunohistochemical results of this clinically sig-
nificant marker in breast tumors (Figure 6).
FFPE tissues represent a valuable resource to conduct
retrospective studies aimed to biomarker discovery and
validation, in cancer as well as other diseases. The most
effective approach may be to both discover and validate
molecular markers on FFPE preparations to decrease
variability potentially induced by tissue handling when
comparing FFPE and frozen samples. In order to im-
prove the ability to characterize proteins from tissues
used for pathological evaluation, a number of steps
could be considered: using a consistent and short period
of fixation in formalin, limiting the duration of time be-
tween tissue collection and addition of formalin, using
small tissue pieces where formalin will permeate more
frequently, obtaining tissue from multiple parts of the
tissue and the consideration of new fixation approaches
that are under development. Clearly, FFPE tissue studies
hold the promise of producing highly reproducible
and meaningful data when linked to powerful high-
throughput methodologies such as reverse-phase protein
arrays.
Materials and methods
Preparation of FFPE cell blocks
MDA-MB-231 and MDA-MB-468 cells were plated in
15 cm Petri dishes, and allowed to grow to 80% conflu-
ence. They were subsequently starved with serum-freemedium overnight and then incubated with EGF or IGF
for 10 minutes for cell signaling stimulation. The starved
and growth factor stimulated cell monolayers were
rinsed twice with TBS (50 mM Tris–HCl pH 7.5 and
150 mM NaCl) and harvested with rubber cell scrapers.
Then cell pellets were processed as fresh frozen or FFPE
cell blocks. Cell pellets were fixed in 10% formalin
(Fisher Scientific, Pittsburgh, PA, USA) for 16 hours,
and embedded in paraffin as a piece of tissue according
to standard histological procedures. Paraffin cell blocks
were stored at room temperature until analysis.
Xenografts and human tissues
The mammary pads of four-week-old female nude mice
were inoculated with 5 × 106 MDA-MB-231 cells. Mice
with mean tumor diameters of 0.5 cm were sacrificed
and the grafted tumors were cut in halves. Half tumor
was fixed in 10% formalin for 24 hours and paraffin em-
bedded using standard procedures; the other half was
immediately snap-frozen and then stored at −80°C until
use. All experiments with mice were performed accord-
ing to the IACUC guidelines for the care and use of liv-
ing animals in scientific research.
Renal tumor, renal cortex and breast tumor tissue
FFPE blocks and their matched frozen pieces from the
same patients were obtained from the University of
Texas MD Anderson Cancer Center tissue bank, follow-
ing Institutional Review Board (IRB) approval and guide-
lines. In the case of renal tissues, the FFPE and matched
frozen preparations were derived from adjacent tissue
pieces, whereas in the case of breast cancer tissues, they
were derived from distant tumor pieces. Renal tissue
samples were confirmed to have at least 70% cellular
content, whereas the breast cancer tissue samples had at
least 50% cellular content. All samples used in the study
were histologically confirmed using H&E.
Deparaffinization and protein extraction
To define technical reproducibility of methodology,
replicates of four serial FFPE cell or tissue sections,
10 μm thick, were placed in Eppendorf tubes and depar-
affinized by incubation at room temperature in xylene
(Fisher Scientific, Pittsburgh, PA, USA) for 10 min. After
each incubation, tissue was pelleted at 14000 × g for
3 min, and incubation/centrifugation steps were
repeated two times. The deparaffinized tissue pellets
were then rehydrated with a graded series of ethanol
(Pharmaco products Inc, Brookfield, IL, USA). The rehy-
drated tumor tissue and cell sections were resuspended
in a panel of extraction buffers as described (see Table 1).
The extraction buffers evaluated included Qproteome
FFPE tissue kit (Qiagen); 20 mM Tris HCl buffers at
various pH values (4, 6 and 9), with 2%(w/v)SDS; the
lysis buffer routinely used for RPPA assay (1% Triton X-
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MgCl2, 1 mM EGTA, 10 mM NaF, 100 mM Na Pyru-
vate, 1 mM Na3VO4, 10% glycerol, containing protease
inhibitors and phosphatase inhibitors from Roche Ap-
plied Science) [9] plus 4 × SDS buffer (3:1, v/v). For tis-
sue samples, the amount of extraction buffer added to
the pellets from paraffin sections was estimated accord-
ing to the size of the tissue surface area. In particular,
tissue blocks were first scanned with an Image Scanner
(CanoScan 8400F, Canon, Lake Success, NY, USA) and
then the surface area of the paraffin-embedded tissue
was calculated using ImageJ (NIH). For frozen samples,
adjustment of buffer volume according to weight of each
frozen piece was performed.
The samples were first incubated on ice for 5 min, and
mixed by vortexing, then boiled at 100°C for 20 min fol-
lowed by an optional sonication step and an optional incu-
bation at 80° C in a water bath for 2 hours. The extraction
methods followed are described in detail in Table 1. After
protein extraction, any remaining unsolubilized material
was pelleted at 14000 × g for 20 min, and protein concen-
tration of total protein extracted was determined by the
BCA Protein Assay (Pierce Chemicals Co., Rockford, IL,
USA). The Pierce BCA Protein Assay is a detergent-
compatible formulation and the protein standards were
prepared using the same lysis buffer as the samples.
SDS-PAGE and western blot
Protein extracts obtained from fresh-frozen and FFPE tis-
sues were subjected to SDS-PAGE in a Bio-Rad Mini
Protean II system. Proteins were stained with Brilliant R
250 according to Westermeier et al. [30]. Parallel gels
were transferred onto PVDF (Polyvinylidene Fluoride,
BioRad, Richmond, USA) membrane. Membranes were
blocked and probed with antibodies against different
sized molecules and visualized using ECL (Amersham/
GE health care).
RPPA assays and analysis
Protein extracts from cell and tissue paraffin blocks were
probed for expression of validated antibodies by RPPA
[9,11,31,32]. Specifically, five serial 2-fold dilutions of the
protein extracts were performed using RPPA lysis buffer
containing 1% SDS. The diluted lysates were spotted on
nitrocellulose-coated FAST slides (Whatman, Schleicher
& Schuell BioScience, Inc., Keene, NH) by an Aushon
2470 arrayer (Aushon Biosystems, Burlington, MA) per
manufacturer’s protocol. The construction of the protein
array is shown in Additional file 5: Figure S1. Each
spotted slide was incubated with a primary antibody
(Additional file 1: Table S1) in the appropriate dilution. A
total of 169 slides were stained for 169 antibodies. The
specific protein-antibody interaction was recognized by
biotin-conjugated secondary antibody and amplified bytyramide deposition. The analyte was detected by avidin-
conjugated peroxidase reactive to its substrate chromogen
diaminobenzidine (DAKO catalyzed signal amplification
(CSA) system, DAKO, Carpinteria, CA). The stained
RPPA slides were scanned by the Hewlett-Packard (HP)
scanner and its companying scanning software, and the
slide images were quantified for raw signal intensities by
the software MicroVigene (VigeneTech Inc., Carlisle, MA)
per manufacturer’s protocol. The raw signal intensities
(which are provided in detail, in Additional files 2, 3 and
4: Tables S2, S3, and S4) were then processed by the R
package SuperCurve [33] developed by the Department of
Bioinformatics and Computational Biology at University
of Texas MD Anderson Cancer Center (http://bioinfor-
matics.mdanderson.org/Software/OOMPA/). The log2-
scaled protein concentrations were normalized by global
sample median normalization (GSMN) (the median of all
protein marker intensities for a single sample is subtracted
from each of the data points of this specific sample
[22,34]). Student’s t test was used to evaluate statistical
significance of differences in protein expression levels
between FFPE and frozen sample groups, or between
PR-negative and PR-positive breast cancer groups, in
order to determine markers with intensity differences be-
tween FFPE and frozen preparations, or between PR-
positive and PR-negative tumors. The reproducibility of
sampling methods was determined by Spearman correl-
ation coefficient. Principal component analysis was per-
formed to show the relatedness of the samples and of the
proteins. All statistical analysis was performed using the
statistics software package R [35].
Additional files
Additional file 1: Table S1. List of the primary antibodies used in the
RPPA experiments.
Additional file 2: Table S2. RPPA raw signal intensities of the cell lines
experiment (FFPE and frozen).
Additional file 3: Table S3. RPPA raw signal intensities of the breast
cancer tissue experiment (FFPE and frozen).
Additional file 4: Table S4. RPPA raw signal intensities of the renal
tissue experiment (FFPE and frozen).
Additional file 5: Figure S1. Protein Microarray Construction. The size,
design and dilution arrangement of the protein microarray are shown.
Additional file 6: Figure S2. SDS-PAGE analysis of protein lysates
extracted from fresh frozen and FFPE cell blocks or xenografts by using
different extraction protocols. (A) Extracts from breast cancer cell lines
incubated with or without EGF were derived from FFPE or fresh
preparations using different extraction methods and subjected to SDS-
PAGE analysis. (B) SDS-PAGE image of protein extracts from fresh frozen
and FFPE xenograft tissues are shown. Lane M: molecular weight marker.
Arrows point to low molecular weight bands attributed to protein
degradation.
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